欢迎来到范德生物BIOFOUNT
范德生物中国

中文范德生物中文语言

范德生物产品购买购物车
0
搜索
(2S,4S,5S)-N-butyl-6-cyclohexyl-4-hydroxy-2-isopropyl-5-((S)-2-((S)-2-(morpholine-4-sulfonamido)-3-phenylpropanamido)pent-4-enamido)hexanamide_150351-30-7_产品详情
150351-30-7
  • (2S,4S,5S)-N-butyl-6-cyclohexyl-4-hydroxy-2-isopropyl-5-((S)-2-((S)-2-(morpholine-4-sulfonamido)-3-phenylpropanamido)pent-4-enamido)hexanamide

  • names:

    (2S,4S,5S)-N-butyl-6-cyclohexyl-4-hydroxy-2-isopropyl-5-((S)-2-((S)-2-(morpholine-4-sulfonamido)-3-phenylpropanamido)pent-4-enamido)hexanamide

  • CAS号:

    150351-30-7

    MDL Number:
  • MF(分子式): C37H61N5O7S MW(分子量): 719.9745
  • EINECS: Reaxys Number:
  • Pubchem ID: Brand:BIOFOUNT
(2S,4S,5S)-N-butyl-6-cyclohexyl-4-hydroxy-2-isopropyl-5-((S)-2-((S)-2-(morpholine-4-sulfonamido)-3-phenylpropanamido)pent-4-enamido)hexanamide
货品编码 规格 纯度 价格 (¥) 现价(¥) 特价(¥) 库存描述 数量 总计 (¥)
FMK23820-500mg 500mg >98% ¥ 0.00 ¥ 0.00 Get quote
- +
¥ 0.00
FMK23820-100mg 100mg >98% ¥ 0.00 ¥ 0.00 Get quote
- +
¥ 0.00
快速询价
收起
你想询价的产品
请准确填写您的联系方式,以便为您提供最好的服务。
中文别名
英文别名 PD 134922
CAS号 150351-30-7
Inchi
InchiKey
分子式 Formula C37H61N5O7S
分子量 Molecular Weight 719.9745
溶解度Solubility
性状
储藏条件 Storage conditions Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
产品说明 (2S,4S,5S)-N-butyl-6-cyclohexyl-4-hydroxy-2-isopropyl-5-((S)-2-((S)-2-(morpholine-4-sulfonamido)-3-phenylpropanamido)pent-4-enamido)hexanamide(CAS:150351-30-7):仅限应用于工业或者科学研究过程中非医疗目的,不应用于人类或动物的临床诊断以及治过程疗,该产品非药用,非食用。
IntroductionPD 134922 is a novel HIV-1 protease inhibitors identified by rational selection.The human immunodeficiency virus (HIV-1), associated with the AIDS (acquired immunodeficiency syndrome) epidemic, encodes an aspartyl protease that is essential for polyprotein processing in the virus (Navia et al., 1989). It has been demonstrated that inactivation of the protease either catalytically or by an inhibitor prevents infectious virion formation (Kohl et al., 1988; Darke et al., 1989). The acquired knowledge of key molecular interactions occurring between inhibitors and aspartyl proteases, as well as the structural similarities between HIV-1 protease and human renin was used to rationally select candidates for HIV-1 screening from the pool of analogs designed as renin inhibitors. A minimal number of chosen compounds were tested in an HIV-1 protease assay system. Two structurally novel peptides emerged as potent enzymatic protease inhibitors.
Application1
Application2
Application3
警示图
危险性 Warning
危险性警示
安全声明
安全防护
备注
    对不起,暂无产品评价!
MSDS
SDS 1.0 中文
展开
SDS 1.0 英文
展开
        新闻
        抱歉,暂无数据!
        My title page contents